Zhang J, Tang H, Liu Z, Chen B. Effects of major parameters of nanoparticles on their physical and chemical properties and the recent application of nano drug delivery system in targeted chemotherapy. Int J Nanomedicine 2017; 12: 8483-93.
Caldorera-Moore M, Guimard N, Shi L, Roy K. Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers. Expert Opin Drug Deliv 2010; 7: 479-95.
Tan J, Shah S, Thomas A, Ou-Yang HD, Liu Y. The influence of size, shape and vessel geometry on nanoparticle distribution. Microfluid Nanofluidics 2013; 14: 77-87.
Zhao Y, Wang Y, Ran F, et al. A comparison between the sphere and rod nanoparticles regarding their in vivo biological behavior and pharmacokinetics. Sci Rep 2017; 7: 4131.
Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol 2015; 33: 941.
Banerjee A, Qi J, Gogoi R, Wong J, Mitragotri S. Role of nanoparticle size, shape and surface chemistry in oral drug delivery. J Control Release 2016; 238: 176-85.
Barua S, Yoo JW, Kolhar P, Wakankar A, Gokarn YR, Mitragotri S. Particle shape enhances specificity of antibody-displaying nanoparticles. Proc Natl Acad Sci 2013; 110: 3270-5.
Nangia S, Sureshkumar R. Effects of nanoparticle charge and shape anisotropy on translocation through cell membranes. Langmuir 2012; 28: 17666-71.
Salatin S. MalekiDizaj S, YariKhosroushahi A. Effect of the surface modification, size, and shape on cellular uptake of nanoparticles. Cell Biol Int 2015; 39: 881-90.
Kolhar P, Anselmo AC, Gupta V, et al. Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium. Proc Natl Acad Sci 2013; 110: 10753-8.
Decuzzi P, Godin B, Tanaka T, et al. Size and shape effects in the biodistribution of intravascularly injected particles. J Control Release 2010; 141: 320-7.
Venkataraman S, Hedrick JL, Ong ZY, et al. The effects of polymeric nanostructure shape on drug delivery. Adv Drug Deliv Rev 2011; 63: 1228-46.
Shah S, Liu Y, Hu W, Gao J. Modeling particle shape-dependent dynamics in nanomedicine. J Nanosci Nanotechnol 2011; 11: 919-28.
Truong NP, Whittaker MR, Mak CW, Davis TP. The importance of nanoparticle shape in cancer drug delivery. Expert Opin Drug Deliv 2015; 12: 129-42.
Hoshyar N, Gray S, Han H, Bao G. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine 2016; 11: 673-92.
Hickey JW, Santos JL, Williford JM, Mao HQ. Control of polymeric nanoparticle size to improve therapeutic delivery. J Control Release 2015; 219: 536-47.
Personick ML, Langille MR, Zhang J, Mirkin CA. Shape control of gold nanoparticles by silver underpotential deposition. Nano Lett 2011; 11(8): 3394-8.
Yaghmur A, Glatter O. Characterization and potential applications of nanostructured aqueous dispersions. . Adv Colloid Interface Sci 2009; 147: 333-42.
Toy R, Hayden E, Shoup C, Baskaran H, Karathanasis E. The effects of particle size, density and shape on margination of nanoparticles in microcirculation. Nanotechnology 2011; 22(11)115101
Rodrigues L, Kyriakos K, Schneider F, et al. Characterization of lipid-based hexosomes as versatile vaccine carriers. Mol Pharm 2016; 13: 3945-54.
Anbarasan B, Fatima GX. Shanmuganathan. S. An overview of Cubosomes-smart drug delivery system. Sri Ramachandra J Med 2015; 8: 1-4.
Karami Z, Hamidi M. Cubosomes: remarkable drug delivery potential. Drug Discov Today 2016; 21: 789-801.
Peng X, Zhou Y, Han K, et al. Characterization of cubosomes as a targeted and sustained transdermal delivery system for capsaicin. Drug Des Devel Ther 2015; 9: 4209-18.
Lakshmi N, Yalavarthi P, Vadlamudi H, Thanniru J, Yaga G. Cubosomes as a targeted drug delivery systems-a biopharmaceutical approach. Curr Drug Discov Technol 2014; 11: 181-8.
Rarokar NR, Khedekar PB. Cubosomes: a vehicle for delivery of various therapeutic agents. MOJ Toxicol 2018; 4: 419-21.
Rizwan SB, Assmus D, Boehnke A, et al. Preparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccines. Eur J Pharm Biopharm 2011; 79: 15-22.
Rattanapak T, Young K, Rades T, Hook S. Comparative study of liposomes, transfersomes, ethosomes and cubosomes for transcutaneous immunisation: characterisation and in vitro skin penetration. J Pharm Pharmacol 2012; 64: 1560-9.
Rizwan SB, McBurney WT, Young K, et al. Cubosomes containing the adjuvants imiquimod and monophosphoryl lipid A stimulate robust cellular and humoral immune responses. J Control Release 2013; 165: 16-21.
Azmi ID, Moghimi SM, Yaghmur A. Cubosomes and hexosomes as versatile platforms for drug delivery. Ther Deliv 2015; 6: 1347-64.
Mionic EM, Petrovic M, Fong WK, Bonvin D, Hofmann H, Milosevic I. Hexosomes with undecylenic acid efficient against Candida albicans. Nanomaterials 2018; 8: 91-103.